National Cancer Institute; Notice of Closed Meetings, 104195-104196 [2024-30326]

Download as PDF Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices webcast, please email IACCPublicInquiries@mail.nih.gov. Disability Accommodations: All IACC Full Committee Meetings provide Closed Captioning through the Zoom platform. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the request. Special requests should be made at least seven (7) business days prior to the meeting; last-minute requests may be made but may not be possible to accommodate. Meeting schedule subject to change. More Information Information about the IACC is available on the website: https:// www.iacc.hhs.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/ about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: December 16, 2024. David W Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–30338 Filed 12–19–24; 8:45 am] ddrumheller on DSK120RN23PROD with NOTICES1 BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Diet, Lipid Metabolism, and Cancer. Date: January 30, 2025. Time: 9:30 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer ,Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248 Rockville, Maryland 20850, 240–672–6175, singhshr@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–5: NCI Clinical and Translational Cancer Research. Date: February 12, 2025. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer ,Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248 Rockville, Maryland 20850, 240–672–6175, singhshr@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed). Date: February 14, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Robert F. Gahl, Ph.D., Scientific Review Officer, Special Review Branch ,Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, Room 7W260 Rockville, Maryland 20850, 240–276–7869, robert.gahl@ nih.gov. PO 00000 Frm 00124 Fmt 4703 Sfmt 4703 104195 Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Prevention Clinical Trials Network—Sites and Data Management. Date: February 14, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–12: NCI Clinical and Translational Cancer Research. Date: February 14, 2025. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Amr M. Ghaleb, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W244, Rockville, Maryland 20850, 240–276–6611, amr.ghaleb@nih.gov Name of Committee: National Cancer Institute Initial Review Group; Career Development Study Section (J). Date: February 19–20, 2025. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850, 240–276–6132, tushar.deb@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SBIR Concept Award TEP. Date: February 21, 2025. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 240–276–5856, nadeem.khan@ nih.gov. E:\FR\FM\20DEN1.SGM 20DEN1 ddrumheller on DSK120RN23PROD with NOTICES1 104196 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–8: NCI Clinical and Translational Cancer Research. Date: February 25, 2025. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W110, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Priya Srinivasan, Ph.D., Scientific Review Officer, Resource and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Rockville, Maryland 20850, 240–276–5619, priya.srinivasan@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–1: SBIR Contract Review Meeting. Date: February 26, 2025. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Cancer Institute at Shady Grove 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Rockville, Maryland 20850, 240–276–7286, salvucco@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–3: SBIR Contract Review. Date: February 27, 2025. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W106, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W106, Rockville, Maryland 20850, 240–276–7975, chufanee@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–6: NCI Clinical and Translational Cancer Research. Date: February 28, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W260, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Robert F. Gahl, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9606 Medical Center Drive, Room 7W260, Rockville, Maryland 20850, 240–276–7869, robert.gahl@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–1: NCI Clinical and Translational Cancer Research. VerDate Sep<11>2014 20:12 Dec 19, 2024 Jkt 265001 Date: March 6, 2025. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Prevention and Control Clinical Trials Planning. Date: March 6, 2025. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Rockville, Maryland 20850, 240–276–5856, nadeem.khan@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–9: SBIR Contract Review Meeting. Date: March 7, 2025. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Prashant Sharma, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W612, Rockville, Maryland 20850, 240–275–6351, prashant.sharma@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–13: NCI Clinical and Translational Cancer Research. Date: March 13, 2025. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: E. Tian, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W618, Rockville, Maryland 20850, 240–276–6611, tiane@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–10: SBIR Contract Review Meeting. PO 00000 Frm 00125 Fmt 4703 Sfmt 4703 Date: March 14, 2025. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240–276–7755, byeong-chel.lee@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Metastasis Research Network (U01). Date: March 21, 2025. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Address: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W120, Rockville, Maryland 20850. Meeting Format: Virtual Meeting. Contact Person: Majed M. Hamawy, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive Room 7W120, Rockville, Maryland 20850, 240–276–6457, mh101v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 16, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–30326 Filed 12–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104195-104196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30326]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and contract proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Diet, Lipid Metabolism, and Cancer.
    Date: January 30, 2025.
    Time: 9:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer ,Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248 Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5: NCI Clinical and Translational Cancer Research.
    Date: February 12, 2025.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Shree Ram Singh, Ph.D., Scientific Review 
Officer ,Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W248 Rockville, Maryland 20850, 240-672-6175, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical 
Trial Not Allowed).
    Date: February 14, 2025.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Robert F. Gahl, Ph.D., Scientific Review 
Officer, Special Review Branch ,Division of Extramural Activities, 
National Cancer Institute, NIH, 9606 Medical Center Drive, Room 
7W260 Rockville, Maryland 20850, 240-276-7869, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Prevention Clinical Trials Network--Sites and Data 
Management.
    Date: February 14, 2025.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-12: NCI Clinical and Translational Cancer Research.
    Date: February 14, 2025.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W244, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Amr M. Ghaleb, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W244, Rockville, Maryland 20850, 240-276-6611, [email protected]

    Name of Committee: National Cancer Institute Initial Review 
Group; Career Development Study Section (J).
    Date: February 19-20, 2025.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W624, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Rockville, Maryland 20850, 240-276-6132, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SBIR Concept Award TEP.
    Date: February 21, 2025.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856, 
[email protected].


[[Page 104196]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
    Date: February 25, 2025.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W110, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Priya Srinivasan, Ph.D., Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-1: SBIR Contract Review Meeting.
    Date: February 26, 2025.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Cancer Institute at Shady Grove 9609 Medical 
Center Drive, Room 7W624, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Rockville, Maryland 20850, 240-276-7286, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-3: SBIR Contract Review.
    Date: February 27, 2025.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W106, Rockville, Maryland 20850, 240-276-7975, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-6: NCI Clinical and Translational Cancer Research.
    Date: February 28, 2025.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W260, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Robert F. Gahl, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9606 Medical Center Drive, Room 
7W260, Rockville, Maryland 20850, 240-276-7869, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1: NCI Clinical and Translational Cancer Research.
    Date: March 6, 2025.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Prevention and Control Clinical Trials Planning.
    Date: March 6, 2025.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-9: SBIR Contract Review Meeting.
    Date: March 7, 2025.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W612, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Prashant Sharma, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W612, Rockville, Maryland 20850, 240-275-6351, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-13: NCI Clinical and Translational Cancer Research.
    Date: March 13, 2025.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: E. Tian, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Rockville, Maryland 20850, 240-276-6611, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-10: SBIR Contract Review Meeting.
    Date: March 14, 2025.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Metastasis Research Network (U01).
    Date: March 21, 2025.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W120, Rockville, Maryland 20850.
    Meeting Format: Virtual Meeting.
    Contact Person: Majed M. Hamawy, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive Room 7W120, Rockville, Maryland 20850, 240-276-6457, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-30326 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.